Amicus Therapeutics, Inc. Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc.

FOLD

Pozycja w akcjach #3694
Amicus Therapeutics, Inc. is a biotechnology firm dedicated to the discovery,... Amicus Therapeutics, Inc. is a biotechnology firm dedicated to the discovery, development, and delivery of medical treatments for rare conditions. Its primary commercial offering is Galafold, an orally administered precision medicine designed for adult patients with a confirmed diagnosis of Fabry disease, specifically those exhibiting an amenable galactosidase alpha gene variant as identified by in vitro assay data. The company's pipeline also includes several investigational therapies: AT-GAA, an innovative treatment strategy for Pompe disease; various enzyme replacement therapies aimed at Pompe diseases; and AT-GTX-502, an AAV serotype gene therapy for CLN3. The latter is currently undergoing Phase 1/2 clinical studies to evaluate the safety and efficacy of a single intrathecal administration in patients with CLN3. Additionally, Amicus is exploring therapeutic approaches related to CDKL5, a gene on the X-chromosome that encodes a protein essential for regulating proper brain development. Amicus maintains strategic collaborations and licensing arrangements with prominent entities such as Nationwide Children's Hospital, the University of Pennsylvania, and GlaxoSmithKline. The company was founded in 2002 and is based in Philadelphia, Pennsylvania.
Cena akcji
$14.49
Ostatnia synchronizacja: 2026-04-27
Kapitalizacja rynkowa
$4.55B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
71.68%
Kraj
US
Handel Amicus Therapeutics, Inc. (FOLD)

Kategoria

Healthcare
Historia podziałów akcji dla Amicus Therapeutics, Inc. (FOLD)
Akcje Amicus Therapeutics, Inc. (symbol: FOLD) przeszły łącznie 0 podziałów.
Najnowszy podział miał miejsce Oct 20, 2026.
Jedna akcja FOLD kupiona przed Oct 20, 2026 odpowiada dziś 0 akcjom FOLD.
Lista podziałów akcji
Rok Podział Mnożnik Skumulowany mnożnik
Za mało danych dla podanych dat.
Podziały akcji dla podobnych firm lub konkurencji
Firma Liczba podziałów akcji Skumulowany mnożnik Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL